Background
==========

We have recently shown that the G protein-coupled receptor 55 (GPR55) responds to some of the cannabinoid and non-cannabinoid ligands in addition to the classical cannabinoid 1 (CB~1~) and 2 (CB~2~) receptors. Here we show multiple signaling pathways triggered by GPR55 in response to its agonists. In addition the cytoskeleton rearrangement mediated by GPR55 is investigated.

Materials and methods
=====================

HEK-293 cells stably expressing the human GPR55 receptor were characterized in terms of signaling properties. To this end, reporter gene, dynamic mass redistribution (DMR), mitogen-activated protein kinases (MAPK) activation and phalloidin actin staining assays have been performed.

Results
=======

Here we show that GPR55 is activated by lysophosphatidylinositol (LPI), AM251, SR141716A (rimonabant) and AM281. GPR55 activation induces NF-κB, NFAT and CREB activation. Stimulation of GPR55 induces F-actin formation under the control of Gα13, RhoA and ROCK. We also show the suitability of Corning^®^ Epic^®^ DMR assay for GPR55 ligand screening. Furthermore, GPR55 activation leads to phosphorylation of extracellular signal-regulated kinase 1/2 (ERK 1/2).

Conclusions
===========

GPR55 as the novel cannabinoid receptor triggers distinct signaling pathways in response to LPI and some classical CB~1~ receptor inverse agonists/antagonists. Stress fiber formation mediated by GPR55 might indicate the probable function of this receptor *in vivo*.
